Search Results - "Whisenant, J.G."

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) by Horn, L., Whisenant, J.G., Wakelee, H., Reckamp, K.L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S.N., Patel, S., Sanborn, R.E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L.P., Li, M., Lovly, C.M.

Get full text

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) by Castelo-Branco, L., Tsourti, Z., Gennatas, S., Rogado, J., Sekacheva, M., Viñal, D., Lee, R., Croitoru, A., Vitorino, M., Khallaf, S., Šušnjar, S., Soewoto, W., Cardeña, A., Djerouni, M., Rossi, M., Alonso-Gordoa, T., Ngelangel, C., Whisenant, J.G., Choueiri, T.K., Dimopoulou, G., Pradervand, S., Arnold, D., Harrington, K., Michielin, O., Dafni, U., Pentheroudakis, G., Peters, S., Romano, E.

“…ESMO COVID-19 and CAncer REgistry (ESMO-CoCARE) is an international collaborative registry-based, cohort study gathering real-world data from Europe,…”
Get full text

Berzosertib. ATR kinase inhibitor, Treatment of solid tumors by Das, S., Berlin, J., Schulten, J., Diaz-Padilla, I., Whisenant, J.G.

Get full text